TREATING VENOUS THROMBOEMBOLISM IN CANCER PATIENTS THE CASE FOR LOW MOLECULAR WEIGHT HEPARIN THERAPY

Tìm thấy 10,000 tài liệu liên quan tới từ khóa "TREATING VENOUS THROMBOEMBOLISM IN CANCER PATIENTS THE CASE FOR LOW MOLECULAR WEIGHT HEPARIN THERAPY":

Cardiovascular disease events within 5 years after a diagnosis of breast cancer

Cardiovascular disease events within 5 years after a diagnosis of breast cancer

Concern for cardiovascular disease (particularly atrial fibrillation-AF) among women with breast cancer is becoming a major issue. We aimed at determining the incidence of cardiovascular disease events (AF, arterial and cardiac events, venous-thromboembolism-VTE) in patients diagnosed with breast ca[r]

Đọc thêm

Evaluation of results of conformal concurrent chemoradiotherapy at the dose of 50.5 Gy in the treatment of non surgical esophageal cancer at 103 Military Hospital

EVALUATION OF RESULTS OF CONFORMAL CONCURRENT CHEMORADIOTHERAPY AT THE DOSE OF 50.5 GY IN THE TREATMENT OF NON SURGICAL ESOPHAGEAL CANCER AT 103 MILITARY HOSPITAL

3. J. Ferlay, I. Soerjomataram, R. Dikshit.Cancer incidence and mortality worldwide:Sources, methods and major patterns inT¹p chÝ y - d−îc häc qu©n sù sè 1-2019GLOBOCAN 2012. J Cancer. 2015, 136 (5),E359-386.Analysis of 869 patients. Radiat OncolBiol Phys. 1989, 16. pp.329-334.4[r]

8 Đọc thêm

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68GaDOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68GaDOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient

Neuroendocrine tumors (NETs) frequently overexpress somatostatin receptors (SSTRs), which is the molecular basis for 68Ga-DOTATOC positron-emission tomography (PET) and radiopeptide therapy (PRRT). However, SSTR expression fluctuates and can be subject to treatment-related changes.

Đọc thêm

ANNUAL UPDATE IN INTENSIVE CARE AND EMERGENCY MEDICINE 2016

ANNUAL UPDATE IN INTENSIVE CARE AND EMERGENCY MEDICINE 2016

broad recognition of antigens, mainly by triggering pathogen-associated molecularpatterns (PAMPs) of lipopolysaccharide (LPS) elements of the surfaces of invading pathogens. When there is an imbalance due to dysregulation of the pro- andanti-inflammatory forces, the local respon[r]

488 Đọc thêm

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: A single-Centre, open-label, randomized, controlled, clinical trial (H

NEOADJUVANT CHEMOTHERAPY VERSUS NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED OESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTRE, OPEN-LABEL, RANDOMIZED, CONTROLLED, CLINICAL TRIAL (H

Neoadjuvant therapy plus oesophagectomy has been accepted as the standard treatment for patients with potentially curable locally advanced oesophageal cancer. No completed randomized controlled trial (RCT) has directly compared neoadjuvant chemotherapy and neoadjuvant chemoradiation in patients with[r]

8 Đọc thêm

TRẮC NGHIỆM LS HARRISONS

TRẮC NGHIỆM LS HARRISONS

17th edition of Harrison’s Principles of Internal Medicine. It isdesigned for the student of medicine to reinforce the knowledge contained in the parent book in an active, rather thanpassive, format. This book contains over 1000 questions,most centered on a patient[r]

491 Đọc thêm

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer

This study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC–CIK) cell therapy in advanced gastrointestinal cancer (GIC).

Đọc thêm

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

A major impediment in the treatment of ovarian cancer is the relapse of chemotherapy-resistant tumors, which occurs in approximately 25% of patients. A better understanding of the biological mechanisms underlying chemotherapy resistance will improve treatment efficacy through genetic testing and nov[r]

Đọc thêm

Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer

Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer

The aim of this study was to gain further investigation of non-small cell lung cancer (NSCLC) tumorigenesis and identify biomarkers for clinical management of patients through comprehensive bioinformatics analysis.

Đọc thêm

Are cancer patients better off if they participate in clinical trials? A mixed methods study

ARE CANCER PATIENTS BETTER OFF IF THEY PARTICIPATE IN CLINICAL TRIALS? A MIXED METHODS STUDY

Research and cancer care are closely intertwined; however, it is not clear whether physicians and nurses believe that clinical trials offer the best treatment for patients and, if so, whether this belief is justified.

17 Đọc thêm

Mapping QTLS associated with root traits related to drought resistance in Vietnamese upland rice

Mapping QTLS associated with root traits related to drought resistance in Vietnamese upland rice

Upland rice grows on 19 million ha, about 15% of the world''s rice plantation [2]. The production of upland rice is crucial to agricultural economy of many countries [15]. The yield of upland rice is very low with an average of about 1 t/ha. Drought is a major constraint to the productivity of uplan[r]

Đọc thêm

393 READING GUILTY FOR ELDERLY ABUSE

393 READING GUILTY FOR ELDERLY ABUSE

Doctor Found Guilty of Elder AbuseFrom a news story byCNN San Francisco Reporter James HattoriJune 12, 2001A jury in Northern California has found a physician liable for elder abuse because he failed toadminister enough pain medication for a terminally ill patient. The ju[r]

3 Đọc thêm

CASE STUDY: JAPANS GREEN POWER CERTIFICATE SCHEME

CASE STUDY: JAPANS GREEN POWER CERTIFICATE SCHEME

Low Carbon Green Growth Roadmap for Asia and the PacificCASE STUDYStimulating consumer interest in businesses that go greenJapan’s Green Power Certificate schemeKey points•Japan’s Green Power Certificate is a successful scheme to publicize, attract and monitor individual[r]

4 Đọc thêm

ATLAS OF SURGERY VOLUME I

ATLAS OF SURGERY VOLUME I

cholangiography. However, in the event that cholangiography has not beenperformed preoperatively, operative cholangiography is performed at the timedsurgery in most patients who prove to have biliary tract stones. Common dudexploration in the absence[r]

474 Đọc thêm

Ebook Nelson’s pediatric antimicrobial therapy (20th edition) Part 2

EBOOK NELSON’S PEDIATRIC ANTIMICROBIAL THERAPY (20TH EDITION) PART 2

(BQ) Part 2 book Nelson’s pediatric antimicrobial therapy presentation of content: Preferred therapy for specific parasitic pathogens, alphabetic listing of antimicrobials, antibiotic therapy for obese children, antibiotic therapy for patients with renal failure, adverse reactions to antimicrobial a[r]

136 Đọc thêm

SIP SMART: A parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer

SIP SMART: A PARALLEL GROUP RANDOMISED FEASIBILITY TRIAL OF A TAILORED PRE-TREATMENT SWALLOWING INTERVENTION PACKAGE COMPARED WITH USUAL CARE FOR PATIENTS WITH HEAD AND NECK CANCER

Dysphagia or difficulty in swallowing affects quality of life for most patients with head and neck cancer. SIP SMART – [Swallowing Intervention Package: Self-Monitoring, Assessment, Rehabilitation Training] aims to improve post-treatment swallowing outcomes through a targeted and tailored pre-treatm[r]

13 Đọc thêm

Ứng dụng trong việc điều trị nhức cơ xương khớp của sóng xung kích Shockwave therapy in musculoskeletal treatment

ỨNG DỤNG TRONG VIỆC ĐIỀU TRỊ NHỨC CƠ XƯƠNG KHỚP CỦA SÓNG XUNG KÍCH SHOCKWAVE THERAPY IN MUSCULOSKELETAL TREATMENT

Shockwave therapy in musculoskeletal treatmentMgr. Ondrej ProuzaPhysiotherapist BTL medical consultant Shockwave therapy Ondrej Prouza2Shockwave therapy contentsContents of presentation:Shockwave Therapy– physical principles technologyShockwave Therapy – medical backgroundShockwave Therapy clin[r]

55 Đọc thêm

NGHIÊN CỨU KẾT QUẢ SÀNG LỌC PHÁT HIỆN UNG THƯ PHỔI Ở ĐỐI TƯỢNG TRÊN 60 TUỔI CÓ YẾU TỐ NGUY CƠ BẰNG CHỤP CẮT LỚP VI TÍNH LIỀU THẤP (TT ANH)

NGHIÊN CỨU KẾT QUẢ SÀNG LỌC PHÁT HIỆN UNG THƯ PHỔI Ở ĐỐI TƯỢNG TRÊN 60 TUỔI CÓ YẾU TỐ NGUY CƠ BẰNG CHỤP CẮT LỚP VI TÍNH LIỀU THẤP (TT ANH)

INTRODUCTION OF THESIS

1. Background:
Lung cancer is one of the common cancers. The disease has the highest incidence and mortality among cancers, most commonly seen in the elderly especially over 60 years old. The majority of lung cancer is related to secondhand and passive smoking and has over[r]

Đọc thêm

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

The prognostic significance of TP53 concurrent mutations in patients with epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)- mutated advanced non–small-cell lung cancer (NSCLC) who received EGFR-tyrosine kinase inhibitors (TKIs) or ALK-TKIs based targeted therapy remains c[r]

Đọc thêm

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer

Although docetaxel-based chemohormonal therapy (CHT) is one of the standard treatments for castration-resistant prostate cancer (CRPC), pertinent biomarkers and precise mechanisms involved in the resistance for CHT for CRPC remain unknown.

Đọc thêm

Cùng chủ đề